BIOMAT Database Logo BIOMAT Database Logo

Using computer-aided drug design and medicinal chemistry strategies in the fight against diabetes. 2011

Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Departamento de Ciencias Farmaceuticas, Faculdade de Ciencias Farmaceuticas de Ribeirao Preto, Universidade de Sao Paulo, Av. do Cafe, s/n, Monte Alegre, 14040-903, Ribeirao Preto-SP, Brazil.

The aim of this work is to present a simple, practical and efficient protocol for drug design, in particular Diabetes, which includes selection of the illness, good choice of a target as well as a bioactive ligand and then usage of various computer aided drug design and medicinal chemistry tools to design novel potential drug candidates in different diseases. We have selected the validated target dipeptidyl peptidase IV (DPP-IV), whose inhibition contributes to reduce glucose levels in type 2 diabetes patients. The most active inhibitor with complex X-ray structure reported was initially extracted from the BindingDB database. By using molecular modification strategies widely used in medicinal chemistry, besides current state-of-the-art tools in drug design (including flexible docking, virtual screening, molecular interaction fields, molecular dynamics, ADME and toxicity predictions), we have proposed 4 novel potential DPP-IV inhibitors with drug properties for Diabetes control, which have been supported and validated by all the computational tools used herewith.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D016208 Databases, Factual Extensive collections, reputedly complete, of facts and data garnered from material of a specialized subject area and made available for analysis and application. The collection can be automated by various contemporary methods for retrieval. The concept should be differentiated from DATABASES, BIBLIOGRAPHIC which is restricted to collections of bibliographic references. Databanks, Factual,Data Banks, Factual,Data Bases, Factual,Data Bank, Factual,Data Base, Factual,Databank, Factual,Database, Factual,Factual Data Bank,Factual Data Banks,Factual Data Base,Factual Data Bases,Factual Databank,Factual Databanks,Factual Database,Factual Databases
D017076 Computer-Aided Design The use of computers for designing and/or manufacturing of anything, including drugs, surgical procedures, orthotics, and prosthetics. CAD-CAM,Computer-Aided Manufacturing,Computer-Assisted Design,Computer-Assisted Manufacturing,Computer Aided Design,Computer Aided Manufacturing,Computer Assisted Design,Computer Assisted Manufacturing,Computer-Aided Designs,Computer-Assisted Designs,Design, Computer-Aided,Design, Computer-Assisted,Designs, Computer-Aided,Designs, Computer-Assisted,Manufacturing, Computer-Aided,Manufacturing, Computer-Assisted

Related Publications

Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Molecular modeling and computer aided drug design. Examples of their applications in medicinal chemistry.
February 2000, Current medicinal chemistry,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Strategies for indirect computer-aided drug design.
April 1993, Pharmaceutical research,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Structure-based drug design strategies in medicinal chemistry.
January 2009, Current topics in medicinal chemistry,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Drug Guru: a computer software program for drug design using medicinal chemistry rules.
October 2006, Bioorganic & medicinal chemistry,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Drug Repositioning Using Computer-aided Drug Design (CADD).
January 2024, Current pharmaceutical biotechnology,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Computer-aided drug design platform using PyMOL.
January 2011, Journal of computer-aided molecular design,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Computer-aided drug design.
March 2023, BMC chemistry,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Computer-aided drug design.
January 1987, Annual review of pharmacology and toxicology,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Computer-aided prediction for medicinal chemistry via the Internet.
January 2008, SAR and QSAR in environmental research,
Evandro P Semighini, and Jonathan A Resende, and Peterson de Andrade, and Pedro A B Morais, and Ivone Carvalho, and Carlton A Taft, and Carlos H T P Silva
Computer-aided Drug Design against Emerging Viruses: Part I.
January 2022, Current topics in medicinal chemistry,
Copied contents to your clipboard!